This Durham company is $20M richer

Durham ’s Heat Biologics (Nasdaq: HTBX) has banked $20.7 million in a public offering of common stock and warrants. The offering was substantially oversubscribed, says Jeff Wolf, founder and CEO of Heat, and positions the company “to achieve many critical milestones over the next five quarters.” “ I think that people are beginning to understand that the immune system has a very big role in combatting cancer, and we look at the immune system almost like an orchestra – where if you only have…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news